Global Home Global Home  
 
 

News

Date Title and Summary Additional Formats
Toggle Summary Blog Coverage Sonoma Pharmaceuticals Announced FDA Clearance For Loyon Skin Descaler
Upcoming AWS Coverage on Amphastar Pharmaceuticals Post-Earnings Results
View HTML
Toggle Summary CORRECTING and REPLACING -- Sonoma Pharmaceuticals Announces Record Quarterly Prescription Data
PETALUMA, Calif. , July 13, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Sonoma Pharmaceuticals, Inc., please note that in the first paragraph of the release the company ticker symbols should be (NASDAQ:SNOA) (SNOAW), not (NASDAQ:OCLS) (OCLSW) as previously
View HTML
Toggle Summary Maxim Group Hosts Key Opinion Leaders Discussing "Breakthroughs in Dermatology" Relating to Products From Oculus Innovative Sciences
Conference Call on February 25, 2016 at 4:15 pm ET
View HTML
Toggle Summary Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery
NORRTALJE, Sweden and PETALUMA, Calif. , March 30, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue care, today announced
View HTML
Toggle Summary Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call
PETALUMA, Calif. , June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. ( NASDAQ : OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ended March 31, 2016 , will be released after the U.S. markets close on June 16, 2016 .
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal First Quarter 2016 Financial Results and Conference Call
PETALUMA, Calif. , July 16, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal first quarter 2016, ended June 30, 2015 , will be released after the U.S. markets close on July 30, 2015 .
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call
PETALUMA, Calif. , July 19, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. ( NASDAQ : OCLS, warrants OCLSW), today announced that the financial results for its fiscal first quarter 2017, ended June 30, 2016 , will be released after the U.S. markets close on July 28, 2016 .
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal Fourth Quarter 2015 Financial Results and Conference Call
PETALUMA, Calif. , May 28, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced that the financial results for its fiscal fourth quarter 2015, ended March 31, 2015 , will be released after the U.S. markets close on June 11, 2015 .
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal Second Quarter 2016 Financial Results and Conference Call
PETALUMA, Calif. , Oct. 22, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), tradable warrants (NASDAQ:OCLSW) today announced that the financial results for its fiscal second quarter 2016, ended September 30, 2015 , will be released after the U.S.
View HTML
Toggle Summary Oculus Innovative Sciences Announces Fiscal Second Quarter 2017 Financial Results and Conference Call
PETALUMA, Calif. , Oct. 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. ( NASDAQ : OCLS, warrants OCLSW), today announced that the financial results for its fiscal second quarter 2017, ended September 30, 2016 , will be released after the U.S. markets close on November 10, 2016 .
View HTML